This Practice Note covers the application of EU competition law to common practices that take place within the pharmaceutical sector. After explaining the definition of market as it applies to the sector, it considers reverse payment patent settlements, pricing strategy, parallel trade, misleading conduct, misuse of regulatory procedures, R&D collaboration agreements as well as mergers and acquisitions.